Percutaneous 60-Day PNS to treat chronic knee pain: Results from a multi-center, retrospective chart review

Friday, November 14, 2025

9:20 AM - 9:28 AM CT

Location: 301 - 302

Introduction:

Chronic knee pain impacts approximately one in four adults and impairs mobility and function¹. Conventional pain treatment options often lack sustained efficacy and can produce unwanted side effects². Percutaneous 60-Day Peripheral Nerve Stimulation (PNS) has demonstrated efficacy for reducing chronic knee pain, including a multicenter randomized placebo-controlled trial for persistent intractable postoperative knee pain³. This multicenter retrospective chart review evaluated the real-world safety and effectiveness of Percutaneous 60-Day PNS in patients treated for knee pain.

Submitting Author(s)

JG

John Gilbert, PhD

Senior Research Engineer
SPR, United States

Co-Author(s)

MA

Mansoor Aman, MD

Pain Management
Aurora Pain Management, United States
GG

Genaro Gutierrez, MD

Medical Director
Ambulatory Surgical Center of Austin, United States
KW

Kevin Walker, MD

Pain Medicine/Anesthesiology
Prisma Health, United States
DD

Daniel Del Gaizo, MD

Orthopedic Surgery
Prisma Health, United States
VP

Vishal Patel, MD

Pain Management
Aurora Pain Management, United States
LL

Lauren Littlefield, MD

Pain Management
Aurora Pain Management, United States
JS

Joshua Smith, MD

Pain Medicine/Anesthesiology
Prisma Health, United States
SP

Shawn Puri, MD

Pain Management
Pain Relief SurgiCenter, United States
JH

Jamal Hasoon, MD

Pain Management
Pain Relief SurgiCenter, United States
DH

David Hall, MD

Pain Medicine/Anesthesiology
Prisma Health, United States

Presenting Author(s)

AW

Amorn Wongsarnpigoon, PhD

Research & Development, Director
SPR, United States

Co-Author(s)

JB

Joseph W. Boggs, PhD

Chief Scientific Officer & Senior Vice President, Research and Development
SPR
Cleveland, Ohio, United States